AVEO Oncology urges stockholders to vote for LG Chem transaction

AVEO Oncology reminds all AVEO stockholders to vote before AVEO’s Special Meeting of Stockholders "FOR" the adoption of the Agreement and Plan of Merger among LG Chem, Ltd, a subsidiary of LG Chem and AVEO. Subject to the terms and conditions of the merger agreement, including obtaining requisite AVEO stockholder approval at the Special Meeting, LG Chem will acquire AVEO for merger consideration of $15.00 per share in cash. The Special Meeting is scheduled for January 5, 2023 at 10:00 a.m. Eastern Time. As previously announced, the Board of Directors of AVEO unanimously recommends that stockholders vote "FOR" the adoption of the merger agreement and each of the other proposals to be voted upon at the Special Meeting. The merger consideration represents a compelling 43% premium to AVEO’s closing price on October 17, 2022.